Tag: Drug Approvals
FDA Approves Kanuma for Lysosomal Acid Lipase Deficiency
For treatment of LAL deficiency, also known as Wolman disease or cholesteryl ester storage disease
FDA Approves Vonvendi to Treat von Willebrand Disease
Approved for the as-needed treatment and control of bleeding episodes in adults
FDA Approves First Flu Vaccine Containing an Adjuvant
Adjuvant can enhance or direct the immune response of the vaccinated individual
FDA Approves Empliciti for Multiple Myeloma
Monoclonal antibody works with another approved therapy to provide additional benefit
FDA Approves Portrazza for Advanced Squamous NSCLC
Drug is designed to block activity of epidermal growth factor receptor protein
FDA Expands Anthrax Vaccine Approval
Now sanctioned for adults 18 to 65 with known or suspected exposure
FDA Approves Opdivo for Advanced Renal Cell Carcinoma
Drug works by targeting the PD-1/PD-L1 cellular pathway
FDA Approves Ninlaro for Multiple Myeloma
New oral medication blocks certain enzymes, hindering cancer-cell growth
FDA Approves Narcan Nasal Spray to Counter Opioid Overdose
First-of-its-kind drug sanctioned to reverse effects of heroin or oxycodone use
FDA Approves Cotellic for Advanced Melanoma
For patients whose tumors express BRAF V600E or V600K mutations
